Heart Rate Evaluation and Resuscitation Trial in Preterm Neonates (HEART)

December 19, 2018 updated by: Vishal Kapadia, University of Texas Southwestern Medical Center
The purpose of this study is to determine whether using electrocardiograms (ECGs) during resuscitation of preterm infants (less than 31 weeks gestation) will decrease the amount of time it takes from birth for heart rate (HR) to be above 100 beats per minute and oxygen saturations to be in the goal range, in other words to stabilize the infant. A few studies have been conducted which showed that ECGs are faster at detecting HR than pulse oximetry (PO). Sample sizes, however, have been small and only few extremely low birthweight infants have been included. It is unclear if use of ECG in these tiny preterm infants in addition to traditional techniques to determine HR will be beneficial and impact resuscitation and outcomes. The investigators propose a study where infants will be randomized to either using ECG in addition to PO ± auscultation versus PO ± auscultation only to assess HR during neonatal resuscitation. The investigators hypothesize that the group of infants randomized to ECG will be able to stabilize faster, i.e. achieve HR > 100 beats per minute and oxygen saturation in goal range faster.

Study Overview

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75235
        • Parkland Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 hour (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Preterm infants less than <31 weeks gestation born at Parkland hospital vaginally or by C/S
  • Infant with congenital heart disease, congenital anomalies, or chromosomal abnormalities will be included unless comfort care has been agreed upon beforehand
  • Resuscitation team present to attend delivery before birth

Exclusion Criteria:

  • Any infant with prenatally agreed upon comfort care since resuscitation will not be provided
  • Any precipitous delivery since resuscitation team will not be in attendance prior to delivery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Pulse oximeter and auscultation to determine heart rate during neonatal resuscitation. Pulse oximeter will be used to determine oxygen saturation.
Control
Experimental: Electrocardiogram group
Electrocardiogram to determine heart rate during neonatal resuscitation. Pulse oximeter will still be used per Neonatal Resuscitation Program guidelines for oxygen saturation.
Experimental

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Infant Stabilization
Time Frame: During delivery room resuscitation, up to 1 hour
Amount of time it takes from birth for heart rate to be above 100 beats per minute and oxygen saturation to be in the goal range (per Neonatal Resuscitation Program guidelines)
During delivery room resuscitation, up to 1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to heart rate >100 beats per minute
Time Frame: During delivery room resuscitation, up to 1 hour
Time in delivery room
During delivery room resuscitation, up to 1 hour
Time to goal oxygen saturation
Time Frame: During delivery room resuscitation, up to 1 hour
Time in delivery room
During delivery room resuscitation, up to 1 hour
Time of positive pressure ventilation
Time Frame: During delivery room resuscitation, up to 1 hour
Total time positive pressure received in delivery room
During delivery room resuscitation, up to 1 hour
Incidence of positive pressure ventilation
Time Frame: During delivery room resuscitation, up to 1 hour
Positive pressure ventilation applied in delivery room
During delivery room resuscitation, up to 1 hour
Incidence of CPR
Time Frame: During delivery room resuscitation, up to 1 hour
CRP applied in delivery room
During delivery room resuscitation, up to 1 hour
Incidence of intubation
Time Frame: During delivery room resuscitation, up to 1 hour
Intubation in delivery room
During delivery room resuscitation, up to 1 hour
Maximum FiO2 applied
Time Frame: During delivery room resuscitation, up to 1 hour
FiO2 applied in delivery room
During delivery room resuscitation, up to 1 hour
Maximum peak inspiratory pressure
Time Frame: During delivery room resuscitation, up to 1 hour
Maximum peak inspiratory pressure in delivery room
During delivery room resuscitation, up to 1 hour
Incidence of hypothermia
Time Frame: Until hospital discharge, up to 6 months
Hypothermia on admission to NICU
Until hospital discharge, up to 6 months
Incidence of need for surfactant
Time Frame: Until hospital discharge, up to 6 months
Surfactant given while in NICU
Until hospital discharge, up to 6 months
Incidence of bronchopulmonary dysplasia
Time Frame: Until hospital discharge, up to 6 months
Incidence in NICU
Until hospital discharge, up to 6 months
Incidence of respiratory distress syndrome
Time Frame: Until hospital discharge, up to 6 months
Incidence in NICU
Until hospital discharge, up to 6 months
Incidence of pneumothorax
Time Frame: Until hospital discharge, up to 6 months
Incidence in NICU
Until hospital discharge, up to 6 months
Incidence of intraventricular hemorrhage
Time Frame: Until hospital discharge, up to 6 months
Incidence in NICU
Until hospital discharge, up to 6 months
Incidence of necrotizing enterocolitis
Time Frame: Until hospital discharge, up to 6 months
Incidence in NICU
Until hospital discharge, up to 6 months
Incidence of sepsis
Time Frame: Until hospital discharge, up to 6 months
Incidence in NICU
Until hospital discharge, up to 6 months
Incidence of symptomatic PDA
Time Frame: Until hospital discharge, up to 6 months
Incidence in NICU
Until hospital discharge, up to 6 months
Incidence of appropriate vs inappropriate use of positive pressure ventilation
Time Frame: During delivery room resuscitation, up to 1 hour
Use in delivery room
During delivery room resuscitation, up to 1 hour
Incidence of equipment failure of pulse oximeter and electrocardiogram
Time Frame: During delivery room resuscitation, up to 1 hour
Failure in delivery room
During delivery room resuscitation, up to 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2017

Primary Completion (Actual)

March 23, 2018

Study Completion (Actual)

March 23, 2018

Study Registration Dates

First Submitted

April 22, 2017

First Submitted That Met QC Criteria

April 25, 2017

First Posted (Actual)

April 28, 2017

Study Record Updates

Last Update Posted (Actual)

December 21, 2018

Last Update Submitted That Met QC Criteria

December 19, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neonatal Resuscitation

Clinical Trials on Pulse oximeter and auscultation group

3
Subscribe